Rhys Ifans (House of the Dragon) is set to lead the cast of Apple TV+‘s upcoming series Star City, a spinoff from the streamer’s space drama For All Mankind. According to sources, Ifans is not ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

Rajeev Juneja, managing director of Mankind Pharma, discusses the company's plans to collaborate with celebrities like Deepika Padukone and Alia Bhatt for advertisements. He praises Anushka Sharma ...

Rajeev highlighted how people from different parts of India had different preferences. Asked which is the highest-selling flavour and the lowest-selling flavour, he said 'chocolate and strawberry ...

Mankind Pharma (Mankind) delivered in-line operational performance for 3QFY25. The earnings were below estimates due to higher interest outgo on debt raised to fund the BSV acquisition.

On Monday, JPMorgan (NYSE:JPM) maintained its Overweight rating on Mankind Pharma Ltd (MANKIND:IN) and increased the price target from INR3,000.00 to INR3,150.00. The adjustment follows the company's ...

On Monday, JPMorgan maintained its Overweight rating on Mankind Pharma Ltd (MANKIND:IN) and increased the price target from INR3,000.00 to INR3,150.00. The adjustment follows the company's third ...

Torrent Pharma reported a 14% YoY rise in Q3FY25 net profit to ₹503 crore, driven by strong India sales growth of 12% and revenue momentum in Germany. ETMarkets.com Torrent Pharma's Q3FY25 profit ...

Mankind Pharma shed 2.76% to Rs 2,560.05 after the company's consolidated net profit declined 16.2% to Rs 380.23 crore in Q3 FY25 as against Rs 453.76 crore posted in Q3 FY24. However, revenue from ...

Mankind Pharma share slipped 5.61 per cent at Rs 2,487.15 a piece on the BSE in Friday’s intraday trade. This came after the Delhi-based pharmaceutical company reported a 16.5 per cent year-on-year (Y ...

Mankind Pharma Ltd.'s share price declined more than 5% during early trade on Friday after the company's third-quarter results showed the consolidated net profit fell, missing analysts' estimates. The ...

Mankind Pharma's shares are in focus following a 16.5% YoY decline in Q3 net profit to Rs 385 crore, despite strong revenue growth of 24%. The company’s domestic business grew by 15.5%, while consumer ...